Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dalian Univ. of Technology HSP90α N-terminus compound 22k
- Development stage
- Unknown
- Lead developer
- Dalian University of Technology
01
Overview
Dalian Univ. of Technology HSP90α N-terminus compound 22k: sourced facts only. name: "22k exhibited a strong affinity for the HSP90α N-terminus with an IC50 value of 0.21 μM." [PMID:36120957]; target: "22k exhibited a strong affinity for the HSP90α N-terminus with an IC50 value of 0.21 μM." [PMID:36120957]; developer: "School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China." [PMID:36120957]
02
Targets
HSP90AA1 (Heat shock protein HSP90-alpha)
Beyond the preview
Go deeper on Dalian Univ. of Technology HSP90α N-terminus compound 22k.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dalian Univ. of Technology HSP90α N-terminus compound 22k.